These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 20586866)
1. Colorectal cancer screening in evolution: Japan and the USA. Ross WA J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S49-56. PubMed ID: 20586866 [TBL] [Abstract][Full Text] [Related]
2. Taishotoyama Symposium Barriers to colorectal cancer screening: economics, capacity and adherence. Inadomi JM J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S198-204. PubMed ID: 19120898 [TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness modeling of colorectal cancer: computed tomography colonography vs colonoscopy or fecal occult blood tests. Lucidarme O; Cadi M; Berger G; Taieb J; Poynard T; Grenier P; Beresniak A Eur J Radiol; 2012 Jul; 81(7):1413-9. PubMed ID: 21444171 [TBL] [Abstract][Full Text] [Related]
4. A decision-analytic evaluation of the cost-effectiveness of family history-based colorectal cancer screening programs. Ramsey SD; Wilschut J; Boer R; van Ballegooijen M Am J Gastroenterol; 2010 Aug; 105(8):1861-9. PubMed ID: 20461066 [TBL] [Abstract][Full Text] [Related]
5. Comparative effectiveness and cost-effectiveness of screening colonoscopy vs. sigmoidoscopy and alternative strategies. Sharaf RN; Ladabaum U Am J Gastroenterol; 2013 Jan; 108(1):120-32. PubMed ID: 23247579 [TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of computerized tomographic colonography versus colonoscopy for colorectal cancer screening. Heitman SJ; Manns BJ; Hilsden RJ; Fong A; Dean S; Romagnuolo J CMAJ; 2005 Oct; 173(8):877-81. PubMed ID: 16217110 [TBL] [Abstract][Full Text] [Related]
8. Potential impact of population-based colorectal cancer screening in Canada. Flanagan WM; Le Petit C; Berthelot JM; White KJ; Coombs BA; Jones-McLean E Chronic Dis Can; 2003; 24(4):81-8. PubMed ID: 14733756 [TBL] [Abstract][Full Text] [Related]
9. A literature review of assumptions on test characteristics and adherence in economic evaluations of colonoscopy and CT-colonography screening. van Gils P; van den Berg M; van Kranen H; de Wit AG Eur J Cancer; 2009 Jun; 45(9):1554-9. PubMed ID: 19261464 [TBL] [Abstract][Full Text] [Related]
10. Projected national impact of colorectal cancer screening on clinical and economic outcomes and health services demand. Ladabaum U; Song K Gastroenterology; 2005 Oct; 129(4):1151-62. PubMed ID: 16230069 [TBL] [Abstract][Full Text] [Related]
11. Is virtual colonoscopy a cost-effective option to screen for colorectal cancer? Sonnenberg A; Delcò F; Bauerfeind P Am J Gastroenterol; 1999 Aug; 94(8):2268-74. PubMed ID: 10445561 [TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of colorectal cancer screening with computed tomography colonography or fecal blood tests. Heresbach D; Chauvin P; Grolier J; Josselin JM Eur J Gastroenterol Hepatol; 2010 Nov; 22(11):1372-9. PubMed ID: 20802341 [TBL] [Abstract][Full Text] [Related]
13. Colon cancer prevention in Italy: cost-effectiveness analysis with CT colonography and endoscopy. Hassan C; Zullo A; Laghi A; Reitano I; Taggi F; Cerro P; Iafrate F; Giustini M; Winn S; Morini S Dig Liver Dis; 2007 Mar; 39(3):242-50. PubMed ID: 17112797 [TBL] [Abstract][Full Text] [Related]
14. Population-based screening for colorectal cancer: Australian research and implementation. Young GP J Gastroenterol Hepatol; 2009 Oct; 24 Suppl 3():S33-42. PubMed ID: 19799696 [TBL] [Abstract][Full Text] [Related]
15. Cost-utility of one-time colonoscopic screening for colorectal cancer at various ages. Ness RM; Holmes AM; Klein R; Dittus R Am J Gastroenterol; 2000 Jul; 95(7):1800-11. PubMed ID: 10925988 [TBL] [Abstract][Full Text] [Related]
16. Colorectal cancer screening behavior in women attending screening mammography: longitudinal trends and predictors. Carlos RC; Fendrick AM; Abrahamse PH; Dong Q; Patterson SK; Bernstein SJ Womens Health Issues; 2005; 15(6):249-57. PubMed ID: 16325138 [TBL] [Abstract][Full Text] [Related]
17. Prospects for population colorectal cancer screening in New Zealand. Parry S; Richardson A; Green T; Marshall B; Bissett I; Bloomfield A; Chadwick V; Cunningham C; Findlay M; Greer B; McMenamin J; Strid J; Robertson G; Teague C N Z Med J; 2007 Jul; 120(1258):U2633. PubMed ID: 17653251 [TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia. Tsoi KK; Ng SS; Leung MC; Sung JJ Aliment Pharmacol Ther; 2008 Aug; 28(3):353-63. PubMed ID: 18638075 [TBL] [Abstract][Full Text] [Related]
19. Effectiveness and economic impact of screening for colorectal cancer by mass fecal occult blood testing. Helm JF; Russo MW; Biddle AK; Simpson KN; Ransohoff DF; Sandler RS Am J Gastroenterol; 2000 Nov; 95(11):3250-8. PubMed ID: 11095350 [TBL] [Abstract][Full Text] [Related]
20. Is the type of Medicare insurance associated with colorectal cancer screening prevalence and selection of screening strategy? Schneider EC; Rosenthal M; Gatsonis CG; Zheng J; Epstein AM Med Care; 2008 Sep; 46(9 Suppl 1):S84-90. PubMed ID: 18725838 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]